Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 4;9:2667–2674. doi: 10.2147/OTT.S98408

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Luo et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Relative miR-199a/b-3p expression levels at second TACE.

Notes: Relative serum miR-199a/b-3p expression levels were measured in the TACE responder group, the TACE nonresponder group, and the total patient group before TACE (t1), 4 days after TACE (t2), 4 weeks after first TACE (t3), and 4 days after second TACE (t4). The miR-199a/b-3p levels of patients in the responder group had a relatively sharp decrease at t2 and t3 compared with the nonresponder group.

Abbreviations: miR-199a/b-3p, microRNA-199a/b-3p; TACE, transarterial chemoembolization.